Cancer
Research and innovation from the oncology experts at Vanderbilt-Ingram Cancer Center
Best Practices Update for Surgical Margins
VUMC oncologists and pathologists update best practices in surgical margins involving bone and soft tissue sarcomas.
Read MoreLatest in Cancer
Signaling Protein in Kidney Cancer Offers Potential Target
Loss of the von Hippel Lindau gene uniquely affects kidney cancer by upregulating a tumor-friendly chemokine.
EHR Holds Clues for Lung Cancer Screening
New tool uncovers information in patient clinic notes to improve lung cancer screening for smokers and former smokers.
Robotic-Assisted Surgery Cuts Recovery Time
Perioperative experiences among pancreatic surgery patients are improved by shorter hospital stays and, thus, accellerated time to therapy.
Partners in Care
Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.
Make a Referral
Examining the Pros and Cons of New Cancer Therapies
A joint study between GE Healthcare and VUMC uses artificial intelligence to identify potential outcomes for cancer therapies.
Gene Variations Linked to Glaucoma Risk
Risk variants of primary open-angle glaucoma may be ancestry-specific, sex-specific, or both.
Nanoparticle Takes Aim at Cancer Defense Shield
Developmental drug aims to undermine tumor calcification, making malignancies more vulnerable to treatment.
Tailored Messaging Aims to Boost Cancer Trial Recruitment
Culturally targeted education could help address cancer disparities among African Americans and Latinos.
3D Scans Provide Surgical Details in Real Time
Researchers develop a process to map and analyze surgical specimens to aid surgeon-pathologist communication.
Tumor-fighting T Cells Tire Quickly
A few hours is all it takes for T cells to become dysfunctional, challenging existing ideas about exhaustion.